Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$247.06 - $1507.4 $59,294 - $361,776
240 Added 187.5%
368 $95,000
Q1 2022

May 10, 2022

BUY
$257.27 - $315.76 $10,805 - $13,261
42 Added 48.84%
128 $38,000
Q3 2020

Nov 06, 2020

SELL
$177.16 - $215.33 $12,401 - $15,073
-70 Reduced 44.87%
86 $19,000
Q2 2020

Jul 15, 2020

BUY
$128.7 - $176.83 $9,009 - $12,378
70 Added 81.4%
156 $28,000
Q4 2019

Feb 05, 2020

SELL
$133.47 - $153.48 $13,347 - $15,347
-100 Reduced 53.76%
86 $13,000
Q3 2019

Oct 31, 2019

BUY
$135.4 - $146.47 $13,540 - $14,647
100 Added 116.28%
186 $27,000
Q3 2018

Nov 07, 2018

BUY
$98.13 - $108.9 $8,439 - $9,365
86 New
86 $9,000
Q2 2018

Jul 31, 2018

SELL
$96.1 - $103.24 $6,919 - $7,433
-72 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$92.16 - $103.8 $7,280 - $8,200
-79 Reduced 52.32%
72 $7,000
Q3 2017

Oct 18, 2017

BUY
$79.29 - $88.45 $11,972 - $13,355
151
151 $13,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Howe & Rusling Inc Portfolio

Follow Howe & Rusling Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.